Navigation Links
A large, observational study of common gout treatment allopurinol shows less than half of patients reach recommended treatment goal
Date:10/28/2013

WILMINGTON, Del.--(BUSINESS WIRE)--AstraZeneca and Ardea Biosciences today presented results from a large study of allopurinol, a treatment commonly used to lower uric acid in patients with gout. The LASSO (Long-term Allopurinol Safety Study evaluating Outcomes in gout patients) study was a multinational, 6-month, open, prospective observational study involving 1,735 patients with gout and was designed to evaluate the safety and efficacy of medically appropriate doses of allopurinol. Results of the LASSO study showed no new safety signals with allopurinol doses of approximately 300mg/day. The study also revealed that at the time of last dose fewer than half (43%) of patients taking allopurinol achieved the target serum uric acid (sUA) level of <6.0 mg/dL, the level recommended by the American College of Rheumatology (ACR) and the European League Against Rheumatism (EULAR). Results of the LASSO study were presented today at the ACR Annual Meeting in San Diego, CA.

Allopurinol, the most commonly used treatment to lower blood uric acid levels in gout, is a generic treatment that has been available for more than 50 years. It is a xanthine oxidase inhibitor, a class of drugs intended to reduce the body's production of uric acid. Allopurinol is recommended at doses between 100mg and 900mg per day, depending upon disease severity. The LASSO study encouraged investigators to increase, or titrate, the dose of allopurinol over the six months of the study to a medically appropriate dose. There was a high rate of adherence to therapy (97% across doses) and the most commonly used dose was 300mg. Approximately 45% of patients finished on the same dose as their baseline dose. Results show that even among patients titrated to final doses above the most commonly used dose of 300mg/day, approximately 46% did not reach target sUA levels of <6.0 mg/dL.

"Gout is a painful form of arthritis that is often misunderstood and inadequately treated. The LASSO study demon
'/>"/>

Contact: Christopher Sampson
Christopher.Sampson@AstraZeneca.com
44-207-604-8279
AstraZeneca
Source:Eurekalert

Page: 1 2 3

Related medicine news :

1. Ms. Viola Richardson, Jersey City Councilwoman-at-Large, Participates in the Annual Steve Sobel SYC 2013 Fencing Competition
2. Study Suggests Vaccine May Help Kids With Brain Cancer
3. Study reveals how cancer drug causes diabetic-like state
4. Coffee Drinking in Pregnancy Wont Lead to Sleepless Baby: Study
5. Lower GI problems plague many with rheumatoid arthritis, Mayo Clinic study finds
6. Veggies Like Broccoli, Cabbage May Help Fight Breast Cancer: Study
7. No Added Cancer Risk From Hip Replacement Materials: Study
8. Reported Decline in U.S. Pneumonia Deaths May Be False: Study
9. Early Study Finds Some Promise for Lung Cancer Vaccine
10. Narcissists Often Ace Job Interviews, Study Finds
11. Sexual objectification of female artists in music videos exists regardless of race, MU study finds
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/30/2014)... 30 August 2014: Transvenous lead extraction (TLE) is clinically ... data from the European Lead Extraction ConTRolled (ELECTRa) registry ... 2014 by Dr Maria Grazia Bongiorni, chair of the ... of cardiac implantable electronic devices (CIED) implant procedures has ... number of complications has increased and leads are often ...
(Date:8/30/2014)... OK (PRWEB) August 30, 2014 In ... valuable, and increasingly difficult to get. Snoring and sleep ... sleep and breathing stops) robs people and their bed ... daily challenges. Up to 45% of the population snores ... have sleep apnea. Of these, only 10% have been ...
(Date:8/30/2014)... Top10BestSEOHosting.com is a well-known review ... that HostGator.com http://secure.hostgator.com/~affiliat/cgi-bin/affiliates/clickthru.cgi?id=seohosts is the best ... they has announced that Bluehost and Arvixe are ... one of the Top 10 Web Hosting in ... hosting, and it offers rich features and great ...
(Date:8/30/2014)... August 30, 2014 Removecomplaints.net, a well-known ... industry, has announced to offer guarantee of results with ... offer this guarantee because of its tremendous track record. ... clients from all over the world and received recommendation ... job. , On being asked about the announcement, ...
(Date:8/30/2014)... LiveStreamingFitness.com, a company dedicated to providing live at ... is proud to announce it has been recognized as one ... solutions by ABC’s Good Morning America. , ... Morning America, “Live Streaming Fitness is the hottest new trend ... streamlining your workout…to boot camp at Life Streaming Fitness for ...
Breaking Medicine News(10 mins):Health News:Transvenous lead extraction clinically successful in 98 percent of cases 2Health News:Transvenous lead extraction clinically successful in 98 percent of cases 3Health News:Snoring: Bad for Relationships, Bad for Health 2Health News:Snoring: Bad for Relationships, Bad for Health 3Health News:Top10BestSEOHosting.com: HostGator.com Is The Best Windows Hosting Supplier 2Health News:Removecomplaints.net Announces Guaranteed Complaints Removal Services 2Health News:LiveStreamingFitness.com is New Trend In Fitness 2
... Conference with Key Legislators, Policy Makers and Celebrities Dedicated to ... , LOS ANGELES and WASHINGTON, June 8 ... non-profit organizations working with at-risk and foster youth in partnership ... and legislators lending their voice the children in need at ...
... and Future Trends , , MOUNTAIN VIEW, Calif., June ... increased awareness and utilization of new tools and approaches to ... cardiac arrhythmia, AFib is the one of the most prevalent ... in the U.S. have AFib, and about one million are ...
... Gentiva Health Services, Inc. (Nasdaq: GTIV ), a ... plans to present at the Jefferies 3rd Annual Healthcare Conference in ... 17, 2009. , , The presentations will be available ... be accessed by visiting http://investors.gentiva.com/events.cfm . ...
... slumber a night, study suggests , MONDAY, June 8 (HealthDay ... be a nocturnal nightmare for some people, new research suggests. ... then spend their days struggling to stay awake. But many ... the study found. , The study revealed that college students, ...
... June 8 Somanetics Corporation (Nasdaq: SMTS ) will ... 2009 before the opening of the market on Wednesday, June 17, ... host a conference call that will be webcast live at 10:00 ... On the conference call, Bruce Barrett, Somanetics, president and chief executive ...
... a leading provider of Business Process Management (BPM), Business ... aligning strategy with execution, today announced that CIO Magazine ... this year,s CIO 100 winners in recognition of its ... largest pharmaceutical and health care products companies. ...
Cached Medicine News:Health News:Children Uniting Nations, Russell Simmons, Mos Def, David Archuleta, Terrence Howard, Gabrielle Union, Vivica Fox, Elise Neal, and Shawn King - Visit Nation's Capitol to Promote Student Mentoring and Change for Child Welfare 2Health News:Frost & Sullivan: Momentum Mounting for Catheter Ablation Technologies in Treatment of Atrial Fibrillation 2Health News:Frost & Sullivan: Momentum Mounting for Catheter Ablation Technologies in Treatment of Atrial Fibrillation 3Health News:Gentiva(R) Health Services to Present at Jefferies 3rd Annual Healthcare Conference 2Health News:Gentiva(R) Health Services to Present at Jefferies 3rd Annual Healthcare Conference 3Health News:Too Much Computer Gaming Can Steal Your Sleep 2Health News:Too Much Computer Gaming Can Steal Your Sleep 3Health News:Somanetics Corporation to Release Second Quarter 2009 Financial Results and Host Conference Call June 17, 2009 2Health News:Metastorm Customer, Wyeth Pharmaceuticals, Wins CIO 100 Award for BPM Project 2
(Date:8/29/2014)... Aug. 29, 2014 /PRNewswire-iReach/ -- Market Research Report ... 2009-2019 is a professional and in-depth market survey ... industry . The report firstly reviews the basic ... application and manufacturing technology. The report then explores ... Scanner listing their product specification, capacity, Production value, ...
(Date:8/29/2014)... 29, 2014  Chuma Holdings, Inc. (OTCBB:CHUM) (the ... turnkey support services for the lawfully organized cannabis ... and approved the Company,s name and symbol change ... will be known as Chuma Holdings, Inc. ... a merger with the Company,s wholly-owned subsidiary, Chuma ...
(Date:8/29/2014)... 2014 The clinical and medical insights provided ... between a product,s success or failure. Despite this, many ... targets – and then to coordinate activities and outreach ... upon which successful KOL engagement rests. ... internal inconsistencies in their KOL management systems and are ...
Breaking Medicine Technology:X-Ray Crystallography Scanner Industry For Global and Chinese Market Forecast to 2019 2X-Ray Crystallography Scanner Industry For Global and Chinese Market Forecast to 2019 3X-Ray Crystallography Scanner Industry For Global and Chinese Market Forecast to 2019 4X-Ray Crystallography Scanner Industry For Global and Chinese Market Forecast to 2019 5CannaMed Announces Name Change and Trading Symbol Change 2CannaMed Announces Name Change and Trading Symbol Change 3Implementing a Strategic Thought Leader Management & Engagement System 2
... BELLEVUE, Wash., Feb. 29, 2012 Talyst , a ... the 8th annual 340B Coalition Winter Conference. The new tool ... The 340B Savings Calculator lets health systems ... http://www.340bsavings.com/ . "Talyst is dedicated to ensure ...
... today announced that it has dosed the first patient ... cancer therapeutic, pegylated arginine deiminase (ADI-PEG 20), in pediatric ... These three cancers represent approximately 50% of all cancers ... with advanced cancers who have failed current therapy will ...
Cached Medicine Technology:Polaris Group Doses First Patient in Phase 1 Clinical Trial of Lead Therapeutic Candidate ADI-PEG 20 in Pediatric Patients with Emphasis on Leukemia, Lymphoma and Sarcoma 2Polaris Group Doses First Patient in Phase 1 Clinical Trial of Lead Therapeutic Candidate ADI-PEG 20 in Pediatric Patients with Emphasis on Leukemia, Lymphoma and Sarcoma 3
For the quantitative determination of Glucose in serum. Endpoint Reaction Product measured at 520 nm. Linearity: 500 mg/dl....
Inorganic phosphorus reagent is used for the quantitative determination of inorganic phosphorus in human serum....
Gamma Glutamyl Transferase reagent is used for the quantitative determination of Gamma -GT in human serum....
For the kinetic quantitative determination of g-Glutamyl Transferase in serum for manual and/or automated procedures....
Medicine Products: